
Scotts Miracle-Gro (SMG) has drawn attention after recent trading, with the stock closing at $61.67 and showing mixed short and longer term returns across the past week, month, past 3 months, and year.
See our latest analysis for Scotts Miracle-Gro.
Recent trading suggests short term momentum is building, with a 7 day share price return of 6.94% and a 30 day share price return of 4.86%, even though the 5 year total shareholder return is down 61.29%.
If this kind of move has you curious about what else is out there, it could be a good time to scan for other opportunities using our 20 top founder-led companies
With Scotts Miracle-Gro trading at $61.67 alongside an indicated intrinsic discount and a gap to analyst targets, the key question is whether the stock is genuinely undervalued or whether the market is already pricing in potential future growth.
According to the most followed narrative on Scotts Miracle-Gro, the fair value sits at $43.49, well below the recent close at $61.67. This puts the spotlight on the assumptions behind that gap.
SMG’s current valuation reflects lingering skepticism: concerns over cannabis demand, consumer spending softness, and execution risk. But it may also underappreciate the company’s positioning within professional cultivation.
It is worth examining what is driving that lower fair value while earnings growth and profit margins look stronger on recent numbers. The narrative leans heavily on long term earnings power, revenue resilience, and profitability assumptions that differ from the market mood. The tension between short term recovery and longer term forecasts is where the full story becomes more nuanced.
Result: Fair Value of $43.49 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this depends on cultivation systems gaining traction, while cannabis end market pressure and any renewed consumer spending weakness do not undercut the higher value activities.
Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.
The narrative driven valuation pins fair value at $43.49 and calls the stock overvalued, but the SWS DCF model points in the opposite direction, with fair value at $77.31 and the current $61.67 price about 20.2% below that level. Which set of assumptions feels more realistic to you?
Look into how the SWS DCF model arrives at its fair value.
If this mix of caution and optimism feels familiar, it is a good moment to look through the numbers yourself and decide what matters most for your portfolio. To help frame that view, take a look at the 5 key rewards and 1 important warning sign.
If this review sparked fresh questions about where to put your next dollar, do not stop here. Broader research now can mean clearer choices later.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com